Homre Ltd sets ₹2.31 floor price for preferential FCW issue

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Homre Limited set the floor price for its preferential FCW issue at ₹2.31 per warrant
  • The company proposes to allot 5,41,12,553 fully convertible warrants
  • Aggregate consideration from the issue amounts to approximately ₹12.50 crore
  • Each warrant is convertible into one equity share with a face value of ₹1
powered bylight_fuzz_icon
49296684

*this image is generated using AI for illustrative purposes only.

Homre Limited has determined the floor price for its proposed preferential issue of fully convertible warrants (FCWs) at ₹2.31 per warrant. The company announced the pricing on August 26, 2026, citing August 25, 2026, as the relevant date for valuation under SEBI ICDR Regulations.

The issue aims to raise aggregate consideration of approximately ₹12.50 crore. The company plans to allot 5,41,12,553 FCWs on a preferential basis. Each warrant carries a face value of ₹1 and is convertible into one equity share of the same face value.

Issue Details

The pricing mechanism adheres to the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018. The floor price serves as the minimum issue price; the actual allotment price will not be lower than this threshold.

Metric Value
Floor Price ₹2.31 per warrant
Number of Warrants 5,41,12,553
Aggregate Consideration ₹12,49,99,997
Conversion Ratio 1:1 (Equity Share)
Relevant Date August 25, 2026

Regulatory Compliance

The intimation was issued to BSE Limited by Bharat Singh Bisht, Whole-Time Director. The proposal is subject to necessary statutory, regulatory, and other approvals before finalization. The company previously operated under the name Triton Corp Limited.

Historical Stock Returns for HOMRE

1 Day5 Days1 Month6 Months1 Year5 Years
+4.62%+3.55%-5.99%+65.85%0.0%0.0%

What is the intended use of the ₹12.50 crore raised through this preferential issue, and how will it impact Homre Limited's operational expansion or debt reduction?

How might the conversion of 5.41 crore warrants into equity shares affect existing shareholders' dilution and the company's earnings per share (EPS) in the long term?

Given the floor price of ₹2.31, what market conditions or investor sentiment factors could influence the final allotment price if it exceeds this threshold?

Homre Ltd approves ₹12.50 crore preferential warrant issue

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights

Homre Limited approved a ₹12.50 crore preferential issue of fully convertible warrants and a new ESOP scheme covering 3 crore options. The warrant issuance involves eight investors, significantly altering the post-conversion shareholding structure. Both proposals require shareholder approval at the upcoming AGM.

powered bylight_fuzz_icon
48685525

*this image is generated using AI for illustrative purposes only.

Homre Limited approved a preferential issue of fully convertible warrants (FCWs) worth up to ₹12.50 crore during its board meeting held on August 19, 2026. The issuance is structured as a private placement under Chapter V of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. Each warrant will be convertible into one equity share of the company.

The board also approved the introduction of the HOMRE ESOP 2026 scheme, which covers up to 3 crore employee stock options. These options are convertible into one equity share each with a face value of ₹1. The exercise price and vesting schedule will be determined by the Nomination and Remuneration Committee in accordance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Warrant Issuance Details

The FCW issue involves eight investors, comprising both promoter and non-promoter groups. The post-issue shareholding pattern assumes full conversion of the warrants based on the issue price determined with reference to August 25, 2026.

Investor Category Pre-Issue Shares Post-Issue Shares Pre-Issue % Post-Issue %
M/s Supriya Securities Pvt. Ltd. (Promoter) 16,10,600 2,16,10,600 0.81% 8.45%
M/s Ganpati Warehousing Limited (Non-Promoter) 1,21,234 3,01,21,234 0.06% 11.78%
Mrs. Mamuni Agrawal (Individual) 37,971 25,37,971 0.02% 0.99%
Mr. Dipesh Kumar Chauhan (Individual) 154,000 6,54,000 0.08% 0.26%

Other non-promoter investors include Mrs. Kusha Dipeshkumar Chauhan, Dipeshkumar Valamjibhai Chauhan HUF, Mrs. Krutika Divyesh Chauhan, and Mr. Divyesh Valamjibhai Chauhan. Their holdings are projected to increase from less than 0.25% individually to between 0.24% and 0.51% post-conversion.

Key Terms and Conditions

Warrant holders may exercise their rights in one or more tranches within 18 months from the date of allotment. Unexercised warrants will lapse after this period, and the subscription amount will be forfeited as per SEBI ICDR Regulations. The issue price is determined in accordance with applicable provisions with reference to the relevant date.

Both the preferential issue and the ESOP scheme are subject to shareholder approval and other statutory regulatory approvals. The company has scheduled its 36th Annual General Meeting for September 24, 2026, to be conducted via Video Conferencing or Other Audio Visual Means.

Administrative Appointments

The board appointed M/s. Datt Ganesh & Associates as Secretarial Auditor for FY26-27 and M/s. S. Lal & Company as Internal Auditor for the same financial year. Mr. Ajay Kumar Choudhary was appointed as Scrutinizer for the upcoming AGM e-voting process. The Register of Members and Share Transfer Books will remain closed from September 19, 2026, to September 24, 2026.

Historical Stock Returns for HOMRE

1 Day5 Days1 Month6 Months1 Year5 Years
+4.62%+3.55%-5.99%+65.85%0.0%0.0%

How might the significant increase in promoter and non-promoter shareholding post-warrant conversion impact Homre Limited's corporate governance and decision-making dynamics?

What specific strategic initiatives or capital expenditures is Homre Limited likely funding with the ₹12.50 crore raised through the FCW issuance?

Given the 18-month exercise window for warrants, how could market volatility between August 2026 and early 2028 influence investor sentiment and potential dilution levels?

More News on HOMRE

1 Year Returns:0.00%